Clinical Trial Update: VNS for Long-COVID-19 [NA]

View source ↗

Summary

Clinical trial update on vagus nerve stimulation for long-COVID-19, including Post-COVID-19 syndrome and related autonomic conditions.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dysautonomia
• Post-acute Sequelae of Sars-cov-2 Infection
• Postural Orthostatic Tachycardia Syndrome

Drugs mentioned

• Vagus nerve stimulation device

Snippet

Sponsor: Icahn School of Medicine at Mount Sinai | Conditions: Post-COVID-19 Syndrome, Postural Tachycardia Syndrome | NA | Status: COMPLETED